Name Development Level Target Family
Name Description
everolimus A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.
TCRDv4.6.9
DrugCentral Indication
DrugCentral
everolimus